Small Animal Imaging In Vivo Market Growth Driven by Advancements in Micro-MRI and Optical Imaging Technologies

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Small Animal Imaging In Vivo Market Size, Share & Trends Analysis Report By Technology (Micro-MRI, Optical, Nuclear imaging, Micro-ultrasound), By Application (Cancer cell detection, Bio-distribution, Monitoring Therapy Response, Longitudinal Studies, Epigenetic Studies)- Market Outlook And Industry Analysis 2031"

The global Small Animal Imaging In Vivo market is estimated to reach over USD 5.11 billion by 2031, exhibiting a CAGR of 9.16% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1665

The small animal imaging (in-vivo) market is expected to experience significant growth in the coming years, driven by increased healthcare spending. Healthcare expenditure, as a percentage of GDP, encompasses both public and private costs, reflecting a broader investment in health services. The rising awareness of self-care management, which leverages technologies such as PET imaging for small animal studies, is further supported by growing healthcare costs. According to the Organization for Economic Co-operation and Development (OECD), health spending as a percentage of GDP increased across member countries, rising from 8.8% in 2019 to 9.7% in 2020. This trend of robust growth continued into 2021, with healthcare spending increasing by nearly 6% across 17 OECD nations.

List of Prominent Players in the Small Animal Imaging In Vivo Market:
• Aspect Imaging Ltd.
• Bruker Corporation
• CMR Naviscan (US)
• FUJIFILM Holdings Corporation
• General Electric (US)
• Hitachi Ltd. (Japan)
• Koninklijke Philips N.V. (Netherlands)
• Life Technologies Corporation
• Mediso Medical Imaging Systems
• Miltenyi Biotech GmbH
• PerkinElmer, Inc.
• Promega Corporation
• SCANCO Medical AG (Switzerland)
• Siemens Healthcare GmbH (Germany)
• Thermo Fisher Scientific

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics:
Drivers:
The growth of the small animal (in-vivo) imaging market is largely driven by the rising costs of healthcare, which is prompting greater adoption of non-invasive imaging technologies. Increased disposable income levels and urbanization are also contributing factors to the market's expansion. Furthermore, increased infrastructure investments in healthcare are expected to accelerate the adoption of small animal imaging. As the global incidence of cancer rises, small animal imaging systems and reagents are finding increasing applications in oncology. Additionally, the growing prevalence of cardiovascular diseases is anticipated to support the market's growth in the cardiology sector.

Challenges:
Despite its potential, the market faces challenges that may slow its growth during the forecast period. Strict regulatory requirements represent a significant barrier, as different regulatory agencies across countries impose varying regulations on medical devices. This lack of standardization complicates product development and market entry for manufacturers. Additionally, the market is hindered by low healthcare spending in developing nations, as well as a shortage of trained professionals and limited awareness, which further restrict its growth prospects.

Regional Trends:
North America is the dominant region in the small animal (in-vivo) imaging market, accounting for approximately 35% of the global market share. This is primarily due to the region's adoption of advanced technologies, heightened healthcare awareness, and favorable reimbursement policies. The significant financial investments in the region, along with the availability of advanced imaging systems such as micro-Photoacoustic tomography (Micro-PAT) in pre-clinical research, further bolster its market leadership. Conversely, the Asia-Pacific region is expected to experience substantial growth, with a projected compound annual growth rate (CAGR) of 11.5%. This growth is largely attributed to the region's untapped market potential and increasing demand for small animal imaging devices.

Unlock Your GTM Strategy:https://www.insightaceanalytic.com/customisation/1665

Recent Developments:
• In November 2021, The establishment of an Advanced In Vivo Imaging Facility at the Indian Institute of Science Education and Research (IISER) Pune has been announced by PerkinElmer India, a leading company dedicated to innovating for a healthier world.

Segmentation of Small Animal Imaging In Vivo Market-
By Technology-
• Micro-MRI
• Optical, Nuclear Imaging
• Micro-Ultrasound
By Application-
• Cancer Cell Detection
• Bio-Distribution
• Monitoring Therapy Response
• Longitudinal Studies
• Epigenetic Studies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report https://www.insightaceanalytic.com/report/small-animal-imaging-in-vivo-market/1665

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.